Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23085760)

1.

The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.

Doçi CL, Zhou G, Lingen MW.

Oncogene. 2013 Sep 12;32(37):4377-86. doi: 10.1038/onc.2012.464. Epub 2012 Oct 22.

PMID:
23085760
2.
3.

Regulation of thrombospondin-1 expression through AU-rich elements in the 3'UTR of the mRNA.

McGray AJ, Gingerich T, Petrik JJ, Lamarre J.

Cell Mol Biol Lett. 2011 Mar;16(1):55-68. doi: 10.2478/s11658-010-0037-x. Epub 2010 Dec 15.

PMID:
21161418
4.

Rapid insulin-like growth factor-1-induced changes in granulosa cell thrombospondin-1 expression in vitro.

McGray AJ, Gingerich T, Petrik JJ, LaMarre J.

J Reprod Dev. 2011 Feb;57(1):76-83.

5.

p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.

Vikhanskaya F, Bani MR, Borsotti P, Ghilardi C, Ceruti R, Ghisleni G, Marabese M, Giavazzi R, Broggini M, Taraboletti G.

Oncogene. 2001 Nov 1;20(50):7293-300.

6.

NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype.

Hasina R, Pontier AL, Fekete MJ, Martin LE, Qi XM, Brigaudeau C, Pramanik R, Cline EI, Coignet LJ, Lingen MW.

Oncogene. 2006 Jan 26;25(4):588-98.

PMID:
16205646
7.

Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.

García-Quiroz J, Rivas-Suárez M, García-Becerra R, Barrera D, Martínez-Reza I, Ordaz-Rosado D, Santos-Martinez N, Villanueva O, Santos-Cuevas CL, Avila E, Gamboa-Domínguez A, Halhali A, Larrea F, Díaz L.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:215-22. doi: 10.1016/j.jsbmb.2013.09.019. Epub 2013 Oct 9.

PMID:
24120914
8.

Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.

Zhou G, Doçi CL, Lingen MW.

BMC Cell Biol. 2010 Sep 27;11:74. doi: 10.1186/1471-2121-11-74.

9.

Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.

Su F, Pascal LE, Xiao W, Wang Z.

Oncogene. 2010 Jan 21;29(3):421-31. doi: 10.1038/onc.2009.326. Epub 2009 Oct 12.

10.

Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Doçi CL, Mankame TP, Langerman A, Ostler KR, Kanteti R, Best T, Onel K, Godley LA, Salgia R, Lingen MW.

Int J Gynecol Pathol. 2012 Jan;31(1):15-24. doi: 10.1097/PGP.0b013e318220ba16.

11.

The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.

Bussolati B, Assenzio B, Deregibus MC, Camussi G.

J Mol Med (Berl). 2006 Oct;84(10):852-63. Epub 2006 Aug 5.

PMID:
16924472
12.

Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.

Laklai H, Laval S, Dumartin L, Rochaix P, Hagedorn M, Bikfalvi A, Le Guellec S, Delisle MB, Schally AV, Susini C, Pyronnet S, Bousquet C.

Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17769-74. doi: 10.1073/pnas.0908674106. Epub 2009 Oct 1.

13.

Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer.

Kim DS, Franklyn JA, Stratford AL, Boelaert K, Watkinson JC, Eggo MC, McCabe CJ.

J Clin Endocrinol Metab. 2006 Mar;91(3):1119-28. Epub 2006 Jan 4.

PMID:
16394085
14.

p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers.

Sundaram P, Hultine S, Smith LM, Dews M, Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, Thomas-Tikhonenko A.

Cancer Res. 2011 Dec 15;71(24):7490-501. doi: 10.1158/0008-5472.CAN-11-1124. Epub 2011 Oct 25.

15.

Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis.

Seki N, Kodama J, Hashimoto I, Hongo A, Yoshinouchi M, Kudo T.

Int J Oncol. 2001 Aug;19(2):305-10.

PMID:
11445843
16.
17.

Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1.

Culp WD, Tsagozis P, Burgio M, Russell P, Pisa P, Garland D.

Mol Cancer Res. 2007 Dec;5(12):1225-31. doi: 10.1158/1541-7786.MCR-07-0229.

18.

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis.

Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA.

Cancer Cell. 2003 Mar;3(3):219-31. Retraction in: Cancer Cell. 2013 Jan 14;23(1):129.

PMID:
12676581
19.

Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.

Zhang J, Ito R, Oue N, Zhu X, Kitadai Y, Yoshida K, Nakayama H, Yasui W.

Virchows Arch. 2003 Jun;442(6):563-8. Epub 2003 Apr 25.

PMID:
12719977
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk